Entrepreneurs from iNANO receive DKK 12m to revolutionise stroke treatment
The spin-out company, MedicQuant, from Aarhus University raises more than DKK 12 million in capital to further develop a rapid analysis tool that will ensure faster treatment of, among other things, blood clots.
The spin-out company, MedicQuant, founded by researchers from iNANO & Dept. of Chemistry at Aarhus University, has the potential to save lives with their newly developed technology.
The founders, Line Debois, Malthe Hansen, and Kurt Gothelf, have designed a groundbreaking technology that can rapidly measure the level of medication in the blood of stroke patients. This gives doctors a more accurate overview – and may reduce mortality and disability in stroke patients.
MedicQuant have now raised more than DKK 12 million in capital, most of which comes from Vækstfonden (The Danish Growth Fund), to further develop the technology.
The health tech company is headed by Line Debois Frejlev Nielsen and Malthe Hansen-Bruhn. Their vision is to create a global business and save lives with MedicQuant's platform technology, which also has potential in other disease areas.
Read the full news article here in MEDWATCH (in Danish).
Contact
CEO Line Debois Frejlev Nielsen
MedicQuant
Email: info@medicquant.com
CTO Malthe Hansen-Bruhn
MedicQuant
Email: info@medicquant.com
Professor Kurt Gothelf
Department of Chemistry & iNANO
Email: kvg@chem.au.dk